Neoadjuvant chemotherapy for primary operable breast cancer: A quality assessment of the NACT-regime
This study aimed to investigate the efficacy of the 2016 guidelines for primary operable breast cancer, initiating with six cycles of neoadjuvant chemotherapy prior to surgery. Findings indicate that this regime is a favourable treatment strategy, as a majority underwent lumpectomies and were spared of axillary dissection
Få tilgang til artikkelen
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.